Liquidia Announces Global Settlement Resolving All Pending Litigation with United Therapeutics, Ensuring Continued Commercialization of YUTREPIA in PAH

Go back to Liquidia Announces Global Settlement Resolving All Pending Litigation with United Therapeutics, Ensuring Continued Commercialization of YUTREPIA in PAH
(NASDAQ: LQDA) Delayed: 38.86 +2.51 (6.91%)
Previous Close $36.35    52 Week High $ 
Open $36.65    52 Week Low $ 
Day High $39.20    P/E N/A 
Day Low $36.51    EPS $ 
Volume 3,883,337